CTLA-4 dimorphisms in gammopathy-associated peripheral neuropathy
- 1 July 1999
- journal article
- clinical trial
- Published by Wiley in European Journal of Neurology
- Vol. 6 (4), 491-493
- https://doi.org/10.1046/j.1468-1331.1999.640491.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studiesActa Neurologica Scandinavica, 2009
- Association of CTLA-4 Gene A-G Polymorphism (IDDM12 Locus) With Acute-Onset and Insulin-Depleted IDDM as Well as Autoimmune Thyroid Disease (Graves' Disease and Hashimoto's Thyroiditis) in the Japanese PopulationDiabetes, 1998
- CTLA4 codon 17 dimorphism in patients with rheumatoid arthritisTissue Antigens, 1998
- Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groupsHuman Molecular Genetics, 1997
- CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves' Disease and to Type 1 Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 1997
- CTLA-4: a negative regulator of autoimmune disease.The Journal of Experimental Medicine, 1996
- An Mse I RFLP in the Human CTLA4 PromotorBiochemical and Biophysical Research Communications, 1996
- The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes RegistryHuman Molecular Genetics, 1996
- Susceptibility to demyelinating polyneuropathy in plasma cell dyscrasia may be influenced by amino acid position 9 of the HLA-DRβ chainJournal of Neuroimmunology, 1993
- A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradationCell, 1986